 BOULDER, Colo., April 29, 2021 GLOBE NEWSWIRE -- Brickell Biotech, Inc. Brickell Nasdaq: BBI, a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that it will report its financial results for the first quarter ended March 31, 2021, after the market close on Thursday, May 13, 2021. Brickells management will host a conference call and webcast at 4:30 pm ET on Thursday, May 13th to discuss the financial results and recent corporate highlights. 